Malin Corporation plc announced the appointment of Dr. Kirsten Drejer and Luke Corning as Non-Executive Directors and Darragh Lyons, Chief Executive Officer, as Executive Director, effective from 24 March 2020. Dr. Kirsten Drejer founded and served as CEO of Symphogen, and has extensive board experience on both private and public companies across the life sciences sector, including Zealand Pharma, where she currently serves as vice-chairman of the board, Bioporto and Alligator Bioscience. Luke Corning is head of the Credit and Special Situations group at Pentwater Capital Management LP. Darragh Lyons was appointed CEO of Malin in September 2019 having previously held the positions of Chief Business and Financial Officer, and Chief Financial Officer of Malin.